✨ Health Notices




29 MARCH 2007 NEW ZEALAND GAZETTE, No. 35

901

Health

Crown Entities Act 2004

Appointment to the Crown Health Financing Agency

Pursuant to section 28(1)(a) of the Crown Entities Act 2004,
I have appointed

Kay McKelvie

as a member of the Crown Health Financing Agency for
a three-year term of office commencing on 1 March 2007.
This appointment was made by way of written notice to the
member (with a copy to the entity) pursuant to section 28(2)
of the Crown Entities Act 2004.

Dated at Wellington this 15th day of March 2007.

PETE HODGSON, Minister of Health.

go2089

Appointment to the Crown Health Financing Agency

Pursuant to section 28(1)(a) of the Crown Entities Act 2004,
I have appointed

David Moore

as a member of the Crown Health Financing Agency for
a three-year term of office commencing on 1 March 2007.
This appointment was made by way of written notice to the
member (with a copy to the entity) pursuant to section 28(2)
of the Crown Entities Act 2004.

Dated at Wellington this 15th day of March 2007.

PETE HODGSON, Minister of Health.

go2088

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of
the new medicines set out in the Schedule hereto:

Schedule

Product:
Apo-Ipravent Nasal Spray 0.03%
Active Ingredient:
Ipratropium bromide monohydrate 0.3g/L
Dosage Form:
Nasal spray solution
New Zealand Sponsor:
Apotex NZ Limited
Manufacturer:
Apotex Inc, Richmond Hill, Ontario, Canada

Product:
Apo-Ipravent Nasal Spray 0.06%
Active Ingredient:
Ipratropium bromide monohydrate 0.6g/L
Dosage Form:
Nasal spray solution
New Zealand Sponsor:
Apotex NZ Limited
Manufacturer:
Apotex Inc, Richmond Hill, Ontario, Canada

Product:
Panadol Cold & Flu Citrus
Active Ingredient:
Paracetamol 500mg
Dosage Form:
Effervescent tablet
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturer:
GlaxoSmithKline Dungarvan Limited, Knockbrack, Dungarvan, Co. Waterford, Ireland

Product:
Vicks VapoRub Cream
Active Ingredients:
Camphor 5.23%w/w
Eucalyptus oil 1.35%w/w
Menthol 2.82%w/w
Dosage Form:
Topical cream
New Zealand Sponsor:
Procter & Gamble Distributing New Zealand
Manufacturer:
Procter & Gamble Manufactura S. De R L de C.V. Col. San Francisco Cuautlalpan, Naucalpan Edo De Mexico C.P., Mexico

Dated this 22nd day of March 2007.

CYNTHIA MALING, Acting-Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health
on 6 July 2001).

go2026

Consent to the Distribution of a New Related Product

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of
the new related product set out in the Schedule hereto:



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2007, No 35


Gazette.govt.nz PDF NZ Gazette 2007, No 35





✨ LLM interpretation of page content

πŸ₯ Appointment to the Crown Health Financing Agency

πŸ₯ Health & Social Welfare
15 March 2007
Appointment, Crown Health Financing Agency, Member
  • Kay McKelvie, Appointed member of Crown Health Financing Agency

  • Pete Hodgson, Minister of Health

πŸ₯ Appointment to the Crown Health Financing Agency

πŸ₯ Health & Social Welfare
15 March 2007
Appointment, Crown Health Financing Agency, Member
  • David Moore, Appointed member of Crown Health Financing Agency

  • Pete Hodgson, Minister of Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
22 March 2007
Medicines, Distribution, Consent, New Medicines
  • Cynthia Maling, Acting-Deputy Director-General, Public Health

πŸ₯ Consent to the Distribution of a New Related Product

πŸ₯ Health & Social Welfare
Medicines, Distribution, Consent, Related Product